Our Mission

"Our research is imperative for medical science moving into the future - and we're uniquely equipped to advance this field and address unmet needs for patients around the world."

Kevin Heyeck, CEO, Chimeron Bio

Dedicated to advancing genetic medicine and transforming cancer treatment. 

Our groundbreaking technology enables unparalleled gene expression and therapeutic potency, making it ideal for developing enhanced in vivo CAR-T therapies.


Our innovative technology is also catalyzing advancements in immuno-oncology and cancer vaccines — offering new hope in the battle against cancer.

Close